TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Hamilton Depression Rating Scale total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite cardiovascular score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perceived value of informational advertisements
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: serum urea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: potassium levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: indoxyl sulfate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Cumulative live birth rate
Endpoint domain: Mortality/survival
Primary endpoint: Ovarian hyperstimulation syndrome cases
Endpoint domain: Adverse events/effects
Primary endpoint: Multiple pregnancy rates
Endpoint domain: Adverse events/effects
Primary endpoint: Onset of major depressive disorder
Endpoint domain: Mortality/survival
Primary endpoint: favourable retinal structural outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean GC‐IPL thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Humphrey visual field mean deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inspiratory strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum estrone concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: serum estradiol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sleep Onset (SO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dim Light Melatonin Onset (DLMO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lung oxygenate index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: t1/2k(e0) values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IC50 values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: locoregional recurrence (LRR)
Endpoint domain: Mortality/survival
Primary endpoint: mean daily-reported muscle stiffness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CWL response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reductions in HOMA-IR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Major cardiovascular disease (CVD) events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interleukin-6 (IL-6) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mean patient satisfaction (CSQ‐8) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Likelihood of referral for specialist care
Endpoint domain: Adverse events/effects
Primary endpoint: Number of teeth filled
Endpoint domain: Physiological/clinical
Endpoint subdomain: Dental outcomes
Primary endpoint: Rate of drug errors per 100 administrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Primary cannulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-ERCP pancreatitis rate
Endpoint domain: Adverse events/effects
Primary endpoint: allograft function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily serving of fruit and vegetable consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Enhanced signal intensity and antigen detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: MPA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: experienced pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Condom nonadherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diaphragm nonadherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 30-day postoperative complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean postsurgical length of stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: vomiting incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: sedation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean acceleration of flow in the pulmonary artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in CCQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Exacerbation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Engagement in physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mean expulsion time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User's manual usefulness rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement in clinical parameters of periodontal disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentages of selected lymphocyte subpopulations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Hemodynamic efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal function (creatinine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Hepatic function (aspartate aminotransferase, alanine aminotransferase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in ADAS cognitive score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of discontinuations
Endpoint domain: Adverse events/effects
Primary endpoint: serum 25(OH)D3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: traumatic injury occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Serum concentrations of pro-inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Invasive diagnostic testing rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Correct estimation of miscarriage risk
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: B-type Natriuretic Peptide (BNP) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite primary outcome (cardiovascular death, myocardial infarction, or stroke)
Endpoint domain: Mortality/survival
Primary endpoint: total daily energy intake (EI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: breast milk consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (anxiety)
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in measures of mood
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement in function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: execution time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: force applied
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptable rate of screw implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: penetration rate of pedicle wall
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: recurrence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence of AK lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Worsening prolapse scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of the 2nd stage of labor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum prolactin content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Length of intensive care unit stays
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flap survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Active dorsiflexion of the ankle joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency of combination therapy in treating bleeding peptic ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: increased walking distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: decreased intensity of calf pain
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Attachment gain of 2 mm or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first antibiotic treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTSD outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: drinking outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: silent aspiration frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall hospital stay
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: mechanical ventilation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34/kg yields
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD34 collection rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of infusion reactions
Endpoint domain: Adverse events/effects
Primary endpoint: plasma arginine fluxes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: arginine oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: gains in elaborated words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of estimated AUC0-12 within ± 15% of observed AUC0-12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac sympathetic nerve activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: surgical workspace
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: target lesion revascularization rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: de novo adhesion formation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Need for opioid analgesics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: consumption of postoperative analgesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: semen volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Composite of death, stroke, embolism, major bleeding or heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Physical/psychological disability requiring alteration of treatment strategy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfactory alignment in primary position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved ocular motility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ipsilateral hypercapnic reactivity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulsatility index increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion with peak flow compared to best/predicted
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: adjusted combined assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of anaesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure-pain threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved remission with budesonide foam versus placebo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Mayo Disease Activity Index rectal bleeding subscale score of 0
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trough inspiratory capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily OFF time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CGI‐Examiner score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UPDRS‐Motor ON score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved insulin sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting total cholesterol, LDL-C, and HDL-C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Postprandial lipemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cost savings with adjunct hypnosis
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Formation of anti-drug antibodies (ADAs)
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of QbTest
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of QbTest implementation
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mortality within the first day after randomization
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in balance-related items of Performance Oriented Mobility Assessment scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 12-month persistence rate
Endpoint domain: Life impact
Endpoint subdomain: Other resource use
Primary endpoint: Improved lipid profiles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduced fasting GLU levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduced blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Tolerance to peanut
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peanut-specific serum IgG(4) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Symptoms of pulmonary obstruction
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of rerupture
Endpoint domain: Mortality/survival
Primary endpoint: Risk of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Mean number of flatus episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean abdominal girth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CGI-I score improvement in RBD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diarrhoea-associated hospitalization rates
Endpoint domain: Mortality/survival
Primary endpoint: 10-year CHD risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: metabolic syndrome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportions achieving the MCIC for VISA-A
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean increases in VISA-A scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FEV1 at 5 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in dyspnoea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: splinted grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: gingival inflammation/bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost savings
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Geometric mean ratio of sitagliptin AUC0‐∞
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geometric mean ratio of sitagliptin Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit rates at 6-week postquit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quit rates at 24-week follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spontaneous recovery of breathing pauses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen saturation (Sp(O2)) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of abnormal vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: transfer to the intensive care unit/high dependency unit
Endpoint domain: Adverse events/effects
Primary endpoint: successful discharge within 24 hours following surgery
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: alcohol reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catheter dysfunction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter survival to first catheter outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRBSI rate
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in anti-sRAGE autoantibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in high-density lipoprotein (HDL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Physical function quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Risk of hip fracture
Endpoint domain: Mortality/survival
Primary endpoint: Understanding of heat-related health issues
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coping strategies for excessive heat
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Full resolution of postoperative nausea and vomiting (PONV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CA125 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgery and hospitalization time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intraoperative bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive alcohol outcome expectancies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Negative alcohol outcome expectancies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Menopausal symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Isometric strength of back extensor muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: efficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: acceptance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CNV prediction performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GA prediction performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean changes of vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in waistline measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in quality of life (IWQOL score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reports of abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean number of emergency department visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean number of hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Prolonged discharge time due to vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean cost per case for anaesthetic drugs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of serum glucose concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decreased total blood cholesterol and low-density lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes